Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

79327933793479357936793779387939794079417942794379447945794679477948794979507951795279537954795579567957795879597960796179627963796479657966796779687969797079717972797379747975797679777978797979807981798279837984Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET,and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previouslyundergone treatment. Radiology. 2010;257:674-84Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET,and/or FDG PET/CT: A meta-analysis of prospective studies including patients who have not previouslyundergone treatment. Radiology 2010;257(3):674-684.Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy of primary chemotherapy in patients withadvanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992;10:904-911.Nordlinger B, Vaillant JC, Guiguet M et al. Survival benefit of repeat liver resections for recurrent colorectalmetastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 1994; 12:1491-1496Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. Aprognostic scoring system to improve case selection, based on 1568 patients. Association Francaise deChirurgie. Cancer 1996;77:1254-1262.Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P e.a. Perioperative chemotherapy withFOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTCIntergroup trial 40983): a randomised controlled trial. Lancet 2008:371:1007-1016Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. EORTC liver metastasesintergroup randomized phase III study40983: long-term survival results. Proc Am Soc Clin Oncol 2012; abstract3508Norum J, Olsen JA. A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer.Ann Oncol. 1997;8(11):1081-7.Noter SL, Rothbarth J, Pijl ME, et al. Isolated hepatic perfusion with high-dose melphalan for the treatment ofuveal melanoma metastases confined to the liver. Melanoma Res. 2004;14:67-72.Nymann T, Jess P, Christiansen J. Rate and treatment of pelvic recurrence after abdominoperineal resection andlow anterior resection for rectal cancer. Dis Colon Rectum. 1995 Aug;38(8):799-802.O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee onCancer sixth edition staging. J Natl Cancer Inst. 2004 Oct 6;96(19):1420-5.O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995;15:25-30.Ohlsson B, Nilsson J, Stenram U, Akerman M, Tranberg KG. Percutaneous fine-needle aspiration cytology in thediagnosis and management of liver tumours. Br J Surg. 2002 ;89:757-762.Ohlsson B, Breland U, Ekberg H, Graffner H, Trannberg KG. Follow-up after curative surgery for colorectalcarcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995,38:619-26.Ohlsson B, Pålsson B. Follow-up after colorectal cancer surgery. Acta Oncol 2003;42(8):816-26.Oka S, Tanaka S, Kanao H, Ishikawa H, Watanabe T, Igarashi M, et al. Mid-term prognosis after endoscopicresection for submucosal colorectal carcinoma: summary of a multicenter questionnaire survey conducted by thecolorectal endoscopic resection standardization implementation working group in Japanese Society for Cancer ofthe Colon and Rectum. Digestive Endoscopy. [Journal ArticleMulticenter Study Research Support Non-U S Gov't]. 2011 Apr 2011;23(2):190-4.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 183